Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/23/1998 | WO1998057635A1 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor |
12/23/1998 | WO1998057634A1 Treatment of diabetes with thiazolidinedione and metformin |
12/23/1998 | WO1998057633A1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER |
12/23/1998 | WO1998057632A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
12/23/1998 | WO1998057631A1 USE OF PPARη AGONISTS FOR INHIBITION OF INFLAMMATORY CYTOKINE PRODUCTION |
12/23/1998 | WO1998057630A1 Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof |
12/23/1998 | WO1998057629A1 Composition for controlling mood disorders in healthy individuals |
12/23/1998 | WO1998057627A1 Dietary compositions for enhancing metabolism and alleviating oxidative stress |
12/23/1998 | WO1998057626A1 Use of l-arginine or a pharmaceutically acceptable salt thereof for production of drugs for treatment of helicobacter pylori infections |
12/23/1998 | WO1998057624A1 Diclofenac solution for topical application |
12/23/1998 | WO1998057623A1 Use of a pharmaceutical composition in the treatment of traumatic arthritis in horses |
12/23/1998 | WO1998057622A1 Synergistic compositions for lycopene and vitamin e for the prevention of ldl oxidation |
12/23/1998 | WO1998057620A2 Inositol for modulation of immune response |
12/23/1998 | WO1998057614A2 Physiological combination of active substances to enhance the skin's defenses against noxious agents |
12/23/1998 | WO1998057545A1 Hypocholesterolemic compositions from bamboo shoots |
12/23/1998 | WO1998045241A3 Lutein esters having high bioavailability |
12/23/1998 | WO1998042868A3 Screening method for proline-rich proteins |
12/23/1998 | WO1998042754A3 Glycosaminoglycans having high antithrombotic activity |
12/23/1998 | WO1998042650A3 Leukotriene antagonists useful for treating cystic fibrosis |
12/23/1998 | WO1998042327A3 Vascular remodeling agent |
12/23/1998 | WO1998042310A3 Fast release compressed tablet of flurbiprofen |
12/23/1998 | WO1998038985A3 Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases |
12/23/1998 | EP0885965A2 Histidine kinase polypeptides |
12/23/1998 | EP0885960A2 G-protein coupled receptor (H7TBA62) |
12/23/1998 | EP0885902A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |
12/23/1998 | EP0885891A1 Isoxazole derivatives |
12/23/1998 | EP0885889A2 Process for the preparation of pyrazole-3-carboxylic acids |
12/23/1998 | EP0885888A1 Isoquinoline derivatives and drugs |
12/23/1998 | EP0885887A2 Sulfonamide inhibitors of HIV-Aspartyl protease |
12/23/1998 | EP0885881A2 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors |
12/23/1998 | EP0885880A2 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors |
12/23/1998 | EP0885612A1 Pirenoxine for the topical treatment of inflammatory conditions |
12/23/1998 | EP0885611A2 Methods and compositions for treating allergic disorders using optically pure (+) cetirizine |
12/23/1998 | EP0885610A1 Tracheal smooth muscle relaxant |
12/23/1998 | EP0885609A1 Use of a pharmaceutical composition in the treatment of traumatic arthritis in horses |
12/23/1998 | EP0885608A1 Remedies for brain diseases |
12/23/1998 | EP0885309A1 Direct molecular diagnosis of friedreich ataxia |
12/23/1998 | EP0885302A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
12/23/1998 | EP0885299A1 Wsx receptor and ligands |
12/23/1998 | EP0885297A1 Novel era |
12/23/1998 | EP0885244A1 Peptide immunogens for vaccination against and treatment of allergy |
12/23/1998 | EP0885239A1 Novel steroid carbamates as potentiating agents |
12/23/1998 | EP0885237A1 Oligonucleotide analogues |
12/23/1998 | EP0885236A1 Oligonucleotide analogs |
12/23/1998 | EP0885234A1 Novel erythromycin derivatives, method for preparing same, and use thereof as drugs |
12/23/1998 | EP0885233A1 Terpyridine-platinum(ii) complexes |
12/23/1998 | EP0885230A1 Camptothecin derivatives and the use thereof as antitumor agents |
12/23/1998 | EP0885229A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
12/23/1998 | EP0885228A1 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
12/23/1998 | EP0885227A1 PYRIMIDO 5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION |
12/23/1998 | EP0885226A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production |
12/23/1998 | EP0885221A1 Azabicyclic esters of carbamic acids useful in therapy |
12/23/1998 | EP0885220A1 Tropane-derivatives, their preparation and use |
12/23/1998 | EP0885218A1 Oxa- and thia-diazole muscarinic receptor antagonists |
12/23/1998 | EP0885217A1 Endothelin receptor antagonists |
12/23/1998 | EP0885215A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
12/23/1998 | EP0885213A1 Fibrinogen receptor antagonists |
12/23/1998 | EP0885212A1 Quinoxalinediones |
12/23/1998 | EP0885211A1 Compounds with a sulfamate group |
12/23/1998 | EP0885210A1 Tricyclic compounds, their production and use |
12/23/1998 | EP0885208A1 Taxoids, their preparation and pharmaceutical compositions containing them |
12/23/1998 | EP0885205A1 Fibrinogen receptor antagonists |
12/23/1998 | EP0885204A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
12/23/1998 | EP0885199A1 Kappa agonist compounds and pharmaceutical formulations thereof |
12/23/1998 | EP0885198A1 4-anilinoquinazoline derivatives |
12/23/1998 | EP0885197A1 2-thioxotetrahydropyrimidin-4-one derivatives |
12/23/1998 | EP0885196A1 Chinoline-2-(1h)-ones |
12/23/1998 | EP0885193A1 Triaryl compounds |
12/23/1998 | EP0885192A1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists |
12/23/1998 | EP0885190A1 Novel n-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties |
12/23/1998 | EP0885188A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
12/23/1998 | EP0885060A1 Solid and semi-solid hydrocarbon gels and uses thereof |
12/23/1998 | EP0885017A2 Use of labelled cck-b receptor ligands for the detection and localization of malignant human tumours |
12/23/1998 | EP0885015A2 Modified cytokines for therapeutic use |
12/23/1998 | EP0885013A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
12/23/1998 | EP0885012A1 Malaria vaccine based upon the addition of a msa1 peptide |
12/23/1998 | EP0885010A1 Intercellular adhesion molecule powder formulation |
12/23/1998 | EP0885009A1 Porphyrins as urokinase-type plasminogen activator receptor antagonists |
12/23/1998 | EP0885008A1 The regulation of appetite, body weight and athletic function with materials derived from citrus varieties |
12/23/1998 | EP0885006A1 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin |
12/23/1998 | EP0885005A2 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men |
12/23/1998 | EP0885004A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
12/23/1998 | EP0885003A1 Use of hexahydrolupulones as antibacterial and anticancer agents |
12/23/1998 | EP0885002A2 Materials and methods for enhancing cellular internalization |
12/23/1998 | EP0884950A1 A method of killing or inhibiting microbial cells |
12/23/1998 | EP0884949A1 Antimicrobial composition, particularly for antisepsis and/or disinfection |
12/23/1998 | EP0884948A1 Antiseptic compositions containing chlorobutanol and chlorhexidine |
12/23/1998 | EP0884947A1 Dna vaccination for induction of suppressive t cell response |
12/23/1998 | EP0778839B1 Novel phosphane oxides, method of preparing them and drugs containing these compounds |
12/23/1998 | EP0759741B1 Mucoadhesive emulsions containing cyclodextrin |
12/23/1998 | EP0729457B1 Diaminocyclobutene-3,4-diones as smooth muscle relaxants |
12/23/1998 | EP0719146B1 Novel method of progesterone delivery and effect thereof |
12/23/1998 | EP0714300B1 Methods for modulating the human sexual response |
12/23/1998 | EP0701546B1 Aromatic acetylcholinesterase inhibitors |
12/23/1998 | EP0693919B1 Oral compositions for treating plaque and gingivitis containing a noncationic antibacterial agent and a bicarbonate salt |
12/23/1998 | EP0683762B1 Acylfulvene analogues as antitumor agents |
12/23/1998 | EP0663826B1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
12/23/1998 | EP0638581B1 Phosphonic diester derivative |
12/23/1998 | EP0631474B1 Cyclic anti-tumor promoter compounds, compositions and methods for production and use |
12/23/1998 | EP0610368B1 Treatment of acne or of pseudofolliculitis barbae |